Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLECA-ED
2024-519233-33-00Phase 3Completed
- Sponsor
- Win Medica
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Atrial fibrillation (AFib) comparing Flecainide arm with Amiodarone arm (2 arms). Primary endpoints: Frequency of successful cardioversion to sinus rhythm within 6 hours and Combined frequency of specific adverse events within 6 hours. Started Jan 2025; status: completed.
02
Drugs
flecainideamiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2024-519233-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519233-33-00.